Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Federal Trade Commission
Cantor Fitzgerald
Mallinckrodt
Daiichi Sankyo
US Department of Justice

Generated: September 23, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,802,735

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,802,735 protect, and when does it expire?

Patent 8,802,735 protects AUBAGIO and is included in one NDA.

This patent has fifty-five patent family members in thirty-eight countries.

Summary for Patent: 8,802,735
Title:(Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability
Abstract: The invention relates to solid pharmaceutical compositions comprising (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide, as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from autoimmune diseases in particular systemic lupus erythematosus or chronic graft-versus-host disease, multiple sclerosis or rheumatoid arthritis.
Inventor(s): Hauck; Gerrit (Frankfurt am Main, DE)
Assignee: Sanofi (Paris, FR)
Application Number:13/422,494
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,802,735
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 8,802,735

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sanofi Aventis Us AUBAGIO teriflunomide TABLET;ORAL 202992-001 Sep 12, 2012 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Sanofi Aventis Us AUBAGIO teriflunomide TABLET;ORAL 202992-002 Sep 12, 2012 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,802,735

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
09290716Sep 18, 2009

International Family Members for US Patent 8,802,735

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 078383 ➤ Sign Up
Australia 2010297357 ➤ Sign Up
Australia 2013257516 ➤ Sign Up
Brazil 112012006184 ➤ Sign Up
Canada 2772275 ➤ Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Moodys
Chubb
AstraZeneca
Deloitte
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.